ADC Therapeutics shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and announced a price target of $11.
ADC Therapeutics SA 0.00%
ADC Therapeutics SA ADCT | 2.93 | 0.00% |
ADC Therapeutics shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and announced a price target of $11.